Time to move on from 'time-to-first': should all events be included in the analysis of clinical trials?
Eur Heart J
.
2012 Nov;33(22):2764-5.
doi: 10.1093/eurheartj/ehs277.
Epub 2012 Aug 27.
Authors
Stefan D Anker
,
John J V McMurray
PMID:
22927554
DOI:
10.1093/eurheartj/ehs277
No abstract available
Publication types
Editorial
Comment
MeSH terms
Benzazepines / therapeutic use*
Cardiotonic Agents / therapeutic use*
Female
Heart Failure, Systolic / drug therapy*
Humans
Ivabradine
Male
Substances
Benzazepines
Cardiotonic Agents
Ivabradine